Health Condition 1: null- Breast ,Gastrointestinal and gyanecological cancers Health Condition 2: N00-N99- Diseases of the genitourinary system Health Condition 3: C260- Malignant neoplasm of intestinal tract, part unspecified Health Condition 4: C50-C50- Malignant neoplasms of breast
Conditions
Interventions
None listed
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 65 years or more starting a new chemotherapy regimen for any GI tumour/ breast/Gyanec cancer.
Exclusion criteria
Exclusion criteria: Patients who are not willing to participate in the study Patient who had already taken any cycle of chemotherapy HIV Tuberculosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the linear relationship between Hurria toxicity prediction score and actual occurrence of grade 3-4 toxicity in the study cohort of elderly patientsTimepoint: 36 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess Clinician accuracy in predicting grade 3-5 toxicity and recording the dose reductions/ modifications pre-emptively; To assess the toxicities of different chemotherapy regimes with cumulative doses in the elderly patients. Timepoint: 36 months | — |
Countries
India
Contacts
Public ContactVikas Ostwal
Tata Memorial Hospital
Outcome results
None listed